US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
ATE139574T1
(de)
*
|
1989-11-06 |
1996-07-15 |
Cell Genesys Inc |
Herstellung von proteinen mittels homologer rekombination
|
EP0779362B2
(de)
*
|
1989-12-22 |
2012-06-13 |
Laboratoires Serono SA |
DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
|
US5272071A
(en)
*
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
GB9028062D0
(en)
*
|
1990-12-24 |
1991-02-13 |
Agricultural & Food Res |
Production of transgenic animals
|
SG93780A1
(en)
*
|
1991-05-06 |
2003-01-21 |
Cell Genesys Inc |
Gene manipulation and expression using genomic elements
|
WO1992021763A1
(en)
*
|
1991-05-31 |
1992-12-10 |
Genentech, Inc. |
Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
|
AU2515992A
(en)
*
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US5641670A
(en)
*
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6270989B1
(en)
*
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US5968502A
(en)
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US20020108136A1
(en)
*
|
1997-03-21 |
2002-08-08 |
Sri |
Transgenic animals produced by homologous sequence targeting
|
AU4401993A
(en)
*
|
1992-06-04 |
1993-12-30 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US5733753A
(en)
*
|
1992-12-22 |
1998-03-31 |
Novo Nordisk A/S |
Amplification of genomic DNA by site specific integration of a selectable marker construct
|
DE69433034T3
(de)
|
1993-04-21 |
2010-04-15 |
The University Court Of The University Of Edinburgh |
Expression von heterologen genen nach einem ziel-expressionsprofil
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US5759775A
(en)
|
1994-10-27 |
1998-06-02 |
Genetech, Inc. |
Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
|
US6610296B2
(en)
|
1995-10-26 |
2003-08-26 |
Genentech, Inc. |
Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
|
IL125073A0
(en)
|
1996-01-08 |
1999-01-26 |
Genentech Inc |
Wsx receptor and ligands
|
US7148004B1
(en)
|
1997-01-16 |
2006-12-12 |
The Rockefeller University |
Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight
|
US7084252B1
(en)
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7063958B1
(en)
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US7619079B2
(en)
|
1996-02-14 |
2009-11-17 |
The Rockefeller University |
Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
|
US5792210A
(en)
*
|
1996-06-10 |
1998-08-11 |
Environmental Behavior Modification Inc. |
Electrical tongue stimulator and method for addiction treatment
|
JP2000517185A
(ja)
|
1996-08-29 |
2000-12-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
新規なメタロプロテアーゼファミリーkuz
|
US6566089B1
(en)
|
1996-09-04 |
2003-05-20 |
Tularik Inc. |
Cell-based drug screens for regulators of gene expression
|
JP4436934B2
(ja)
*
|
1996-09-13 |
2010-03-24 |
ノボザイムス,インコーポレイティド |
変更された量のポリペプチドを生成するdna挿入突然変異を有する細胞
|
JPH10117771A
(ja)
*
|
1996-10-23 |
1998-05-12 |
Natl Food Res Inst |
冷凍生地耐性実用パン酵母
|
US5925544A
(en)
*
|
1996-11-18 |
1999-07-20 |
Novo Nordisk A/S |
Method of homologous recombination followed by in vivo selection of DNA amplification
|
CA2276064C
(en)
|
1997-01-17 |
2013-12-17 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
*
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
RO120148B1
(ro)
|
1997-03-14 |
2005-09-30 |
Idec Pharmaceuticals Corporation |
Sistem vector şi procedeu de inserţie a unui fragment adn, în genomul celulelor de mamifere
|
US5948653A
(en)
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
US6172211B1
(en)
|
1997-07-11 |
2001-01-09 |
Boehringer Ingelheim International Gmbh |
Nucleic acid encoding tag7 polypeptide
|
KR100622203B1
(ko)
|
1997-07-23 |
2006-09-07 |
로셰 디아그노스틱스 게엠베하 |
내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
|
US6548296B1
(en)
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
AU754619B2
(en)
*
|
1997-07-23 |
2002-11-21 |
Roche Diagnostics Gmbh |
Production of erythropoietin by endogenous gene activation
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
BR9811542A
(pt)
|
1997-07-23 |
2000-08-22 |
Roche Diagnostics Gmbh |
Identificação de linhas de células humanas para a produção de proteìnas humanas mediante ativação de genes endógena
|
AU750025B2
(en)
*
|
1997-09-26 |
2002-07-11 |
Athersys, Inc. |
Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US6740503B1
(en)
|
1997-09-26 |
2004-05-25 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
ZA989497B
(en)
†
|
1997-10-20 |
2000-04-19 |
Roche Diagnostics Gmbh |
Positive-negative selection in homologous recombination.
|
BR9814912A
(pt)
|
1997-11-28 |
2000-10-03 |
Genset Sa |
Sequência genÈmica e polipeptìdeos de chlamydia trachomatis, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
|
AU757930B2
(en)
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
JPH11243944A
(ja)
*
|
1998-03-04 |
1999-09-14 |
Natl Food Res Inst |
製パン用乾燥耐性実用パン酵母
|
US6294655B1
(en)
|
1998-04-03 |
2001-09-25 |
Hyseq, Inc. |
Anti-interleukin-1 receptor antagonist antibodies and uses thereof
|
US6426191B1
(en)
|
1998-04-03 |
2002-07-30 |
Hyseq, Inc. |
Assays involving an IL-1 receptor antagonist
|
US6541623B1
(en)
|
1998-04-03 |
2003-04-01 |
Hyseq, Inc. |
Interleukin—1 receptor antagonist and uses thereof
|
US6337072B1
(en)
|
1998-04-03 |
2002-01-08 |
Hyseq, Inc. |
Interleukin-1 receptor antagonist and recombinant production thereof
|
WO2000005393A2
(en)
|
1998-07-21 |
2000-02-03 |
Cobra Therapeutics Limited |
A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
|
JP4486256B2
(ja)
*
|
1998-10-22 |
2010-06-23 |
ザ・ジェネラル・ホスピタル・コーポレイション |
副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
TW570977B
(en)
*
|
1998-12-07 |
2004-01-11 |
Li-Wei Hsu |
An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
DK2067788T3
(da)
|
1999-05-18 |
2015-10-19 |
Dyax Corp |
Fab-fragmentbiblioteker og fremgangsmåder til anvendelse deraf
|
US6495360B1
(en)
*
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
US20050129669A1
(en)
*
|
1999-06-21 |
2005-06-16 |
Transkaryotic Therapies, Inc., A Massachusetts Corporation |
DNA construct for effecting homologous recombination and uses thereof
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
WO2001023521A2
(en)
*
|
1999-09-29 |
2001-04-05 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
WO2001023427A1
(en)
|
1999-09-29 |
2001-04-05 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
EP1266016A2
(de)
*
|
2000-01-13 |
2002-12-18 |
Novozymes Biotech, Inc. |
Methoden zur produktion eines polypeptids durch benutzung einer verkrüppelten translationalen startseqeunz
|
WO2001064882A2
(en)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US6686188B2
(en)
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
GB0018876D0
(en)
*
|
2000-08-01 |
2000-09-20 |
Applied Research Systems |
Method of producing polypeptides
|
EA013564B1
(ru)
*
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
US6803211B2
(en)
|
2000-08-25 |
2004-10-12 |
Pfizer Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
CA2430989A1
(en)
|
2000-12-06 |
2002-06-13 |
Robert J. Hariri |
Method of collecting placental stem cells
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
CN100528235C
(zh)
*
|
2000-12-20 |
2009-08-19 |
霍夫曼-拉罗奇有限公司 |
红细胞生成素共轭物
|
ATE505204T1
(de)
|
2000-12-20 |
2011-04-15 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
EP2316919B1
(de)
|
2001-02-14 |
2015-10-07 |
Anthrogenesis Corporation |
Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
|
WO2002063962A1
(en)
|
2001-02-14 |
2002-08-22 |
Hariri Robert J |
Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
ATE404672T1
(de)
|
2001-06-06 |
2008-08-15 |
Bioriginal Food & Science Corp |
Samen-spezifische sequenzen aus flachs (linum usitatissimum l.)
|
EP1925671A1
(de)
|
2001-06-06 |
2008-05-28 |
Bioriginal Food & Science Corp. |
Flax-(Linum usitatissimum L.)-Samenspezifische Promotoren
|
WO2003009804A2
(en)
*
|
2001-07-23 |
2003-02-06 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
JP2005511500A
(ja)
|
2001-08-31 |
2005-04-28 |
ザ ロックフェラー ユニバーシティー |
脳におけるホスホジエステラーゼ活性およびホスホジエステラーゼ1b媒介シグナル伝達の調節
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
US20030170691A1
(en)
|
2001-12-19 |
2003-09-11 |
Millennium Pharmaceuticals, Inc. |
Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
|
KR100982922B1
(ko)
*
|
2002-01-17 |
2010-09-20 |
론자 바이올로직스 피엘씨 |
단백질을 생산할 수 있으며 무글루타민 배지에서 성장할 수있는 글루타민-요구성 인간세포
|
EP2292091A1
(de)
|
2002-02-13 |
2011-03-09 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
US20060052320A1
(en)
*
|
2002-05-06 |
2006-03-09 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
|
US7205398B2
(en)
|
2002-05-24 |
2007-04-17 |
Schering-Plough Animal Health Corporation |
Eta-1 gene and methods for use
|
AU2003265525A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
AU2003268135A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US20050037011A1
(en)
|
2002-11-21 |
2005-02-17 |
Jones Stephen N. |
Diagnosing and treating hematopoietic cancers
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
KR101042448B1
(ko)
|
2002-11-26 |
2011-06-16 |
안트로제네시스 코포레이션 |
세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
WO2004063356A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Rao Mahendra S |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
CA2513251C
(en)
|
2003-01-14 |
2013-03-19 |
Dana-Farber Cancer Institute |
Cancer therapy sensitizer
|
US8021833B2
(en)
|
2003-02-12 |
2011-09-20 |
Functional Genetics, Inc. |
Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
|
EP2201960A1
(de)
*
|
2003-03-19 |
2010-06-30 |
The General Hospital Corporation |
Konformationseingeschränkte Parathormone mit Alpha-Helix-Stabilisatoren
|
WO2005009358A2
(en)
|
2003-07-17 |
2005-02-03 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
US7287952B2
(en)
*
|
2003-07-23 |
2007-10-30 |
Lockheed Martin Corporation |
Feeder load automation system and method of use
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EA010650B1
(ru)
|
2003-09-29 |
2008-10-30 |
Уоррен Фармасьютикалз, Инк. |
Защищающие ткань цитокины для лечения и профилактики сепсиса и образования спаек
|
EP1694706B1
(de)
|
2003-11-01 |
2012-04-04 |
Merck Patent GmbH |
Modifizierter anti-cd52-antikörper
|
EP1696947B1
(de)
*
|
2003-12-19 |
2014-02-26 |
F.Hoffmann-La Roche Ag |
Verwendung von erythropoietin zur behandlung von störungen des eisen verteilung in chronische entzündliche darmerkrankungen
|
ATE409741T1
(de)
*
|
2004-01-19 |
2008-10-15 |
Nsgene As |
Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen
|
WO2006017621A2
(en)
|
2004-08-02 |
2006-02-16 |
Janssen Pharmaceutica N.V. |
IRAK1c SPLICE VARIANT AND ITS USE
|
US7893197B2
(en)
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
EP2338994B1
(de)
|
2004-09-02 |
2014-03-19 |
Yale University |
Regulierung von Onkogenen durch mikro-RNAs
|
CA3079874C
(en)
|
2004-10-22 |
2023-01-03 |
Revivicor, Inc. |
Ungulates with genetically modified immune systems
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US20090311247A1
(en)
*
|
2005-01-25 |
2009-12-17 |
Apollo Life Sciences Limited |
Molecules and chimeric molecules thereof
|
EP1846560A4
(de)
|
2005-02-09 |
2009-02-11 |
Bioriginal Food & Science Corp |
Neue mitglieder der omega-3-fettsäure-desaturase-familie und deren verwendungen
|
JP5666087B2
(ja)
|
2005-04-06 |
2015-02-12 |
アダマス・ファーマシューティカルズ・インコーポレーテッド |
Cns関連疾患の治療のための方法及び組成物
|
US8354384B2
(en)
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
NZ597304A
(en)
|
2005-10-13 |
2013-06-28 |
Anthrogenesis Corp |
Immunomodulation using placental stem cells
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
AU2006332679A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
JP5550235B2
(ja)
|
2005-12-29 |
2014-07-16 |
アントフロゲネシス コーポレーション |
胎盤幹細胞集団
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
SI2004683T1
(sl)
|
2006-03-24 |
2016-09-30 |
Biogen Hemophilia Inc. |
Pc5 kot encim za obdelavo propeptida faktorja ix
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
CA2659990C
(en)
*
|
2006-08-04 |
2016-03-22 |
Prolong Pharmaceuticals, Inc. |
Polyethylene glycol erythropoietin conjugates
|
EP2054077A4
(de)
*
|
2006-08-04 |
2010-10-13 |
Gen Hospital Corp |
Polypeptidderivate des parathyroidhormons (pth)
|
PL2064325T3
(pl)
|
2006-09-01 |
2012-05-31 |
Therapeutic Human Polyclonals Inc |
Zwiększona ekspresja ludzkiej lub humanizowanej immunoglobuliny u zwierząt transgenicznych innych niż człowiek
|
CN104099290A
(zh)
|
2006-10-23 |
2014-10-15 |
人类起源公司 |
用胎盘细胞群治疗骨缺损的方法和组合物
|
EP2078075B1
(de)
|
2006-10-30 |
2015-09-02 |
Eli Lilly and Company |
Verbesserte antikörperproduktion durch rhgp (random homozygous gene pertubation)
|
CN103356711A
(zh)
|
2007-02-12 |
2013-10-23 |
人类起源公司 |
利用胎盘干细胞治疗炎性疾病
|
US20110189663A1
(en)
|
2007-03-05 |
2011-08-04 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008141176A1
(en)
|
2007-05-11 |
2008-11-20 |
The Trustees Of The University Of Pennsylvania |
Methods of treatment of skin ulcers
|
KR101461659B1
(ko)
|
2007-05-11 |
2014-11-17 |
토마스 제퍼슨 유니버시티 |
신경변성 질환 및 장애의 치료 및 예방 방법
|
CA2691539C
(en)
|
2007-06-21 |
2014-08-26 |
Angelica Therapeutics, Inc. |
Modified toxins
|
AR067537A1
(es)
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Purificacion de polipeptidos pegilados
|
AR067536A1
(es)
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
US8568737B2
(en)
*
|
2007-08-01 |
2013-10-29 |
The General Hospital Corporation |
Screening methods using G-protein coupled receptors and related compositions
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
EP2573104A1
(de)
|
2007-09-24 |
2013-03-27 |
Cornell University |
Immunogene Proteine aus der genombasierten äußeren Membran von Leptospira sowie darauf basierende Zusammensetzungen und Verfahren
|
AU2008307633C1
(en)
|
2007-09-28 |
2015-04-30 |
Celularity Inc. |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
WO2009089120A2
(en)
|
2008-01-02 |
2009-07-16 |
Suregene Llc |
Genetic markers of mental illness
|
EP2581457A3
(de)
|
2008-01-17 |
2013-07-17 |
Suregene LLC |
Genetische Marker von Geisteskrankheiten
|
CA2717169A1
(en)
*
|
2008-03-01 |
2009-09-17 |
Abraxis Bioscience, Llc |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
JP5670755B2
(ja)
|
2008-03-12 |
2015-02-18 |
ザ ロックフェラー ユニバーシティ |
翻訳プロファイリング及び分子表現型解析のための方法及び組成物
|
EP2288704A2
(de)
*
|
2008-05-07 |
2011-03-02 |
Abraxis BioScience, LLC |
Verbesserte wirkstofftherapie mittels mirna
|
JP6169316B2
(ja)
|
2008-08-20 |
2017-07-26 |
アンスロジェネシス コーポレーション |
改良型細胞組成物およびその作製方法
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2344672B8
(de)
|
2008-09-25 |
2014-12-24 |
SureGene LLC |
Genetische marker zur optimierung einer schizophreniebehandlung
|
ES2592216T3
(es)
|
2008-09-26 |
2016-11-28 |
Dana-Farber Cancer Institute, Inc. |
Anticuerpos anti-PD-1, PD-L1 y PD-L2 humanos y sus usos
|
US8110185B2
(en)
*
|
2008-10-03 |
2012-02-07 |
St. Michael's Hospital |
Method for preventing and treating cardiovascular diseases with BRCA1
|
US20100120063A1
(en)
*
|
2008-10-10 |
2010-05-13 |
Discoverx Corporation |
GPCR Arrestin Assays
|
EP2348827B1
(de)
|
2008-10-27 |
2015-07-01 |
Revivicor, Inc. |
Immunsupprimierte huftiere
|
ES2723098T3
(es)
|
2008-11-04 |
2019-08-21 |
Janssen Pharmaceutica Nv |
Agonistas del péptido CRHR2 y usos de los mismos
|
RU2562154C2
(ru)
|
2008-11-19 |
2015-09-10 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
EP2379720B1
(de)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Durch den promoter mir-21 angetriebene gezielte krebstherapie
|
WO2010088522A2
(en)
|
2009-01-30 |
2010-08-05 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and uses therefor
|
US8211655B2
(en)
*
|
2009-02-12 |
2012-07-03 |
Discoverx Corporation |
Wild-type receptor assays
|
KR20120103606A
(ko)
|
2009-11-04 |
2012-09-19 |
얀센 파마슈티카 엔.브이. |
스트레스코핀-유사 펩타이드를 이용해 심부전을 치료하는 방법
|
EP2499159B1
(de)
|
2009-11-13 |
2017-01-04 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
US9260517B2
(en)
|
2009-11-17 |
2016-02-16 |
Musc Foundation For Research Development |
Human monoclonal antibodies to human nucleolin
|
WO2011087760A2
(en)
|
2009-12-22 |
2011-07-21 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
ES2646750T3
(es)
|
2010-01-26 |
2017-12-15 |
Anthrogenesis Corporation |
Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
|
WO2011094593A2
(en)
|
2010-01-28 |
2011-08-04 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and methods of marking the same
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
KR20190076060A
(ko)
|
2010-04-07 |
2019-07-01 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 혈관신생
|
US9492508B2
(en)
|
2010-05-13 |
2016-11-15 |
The General Hospital Corporation |
Parathyroid hormone analogs and uses thereof
|
WO2012009422A1
(en)
|
2010-07-13 |
2012-01-19 |
Anthrogenesis Corporation |
Methods of generating natural killer cells
|
WO2012018387A2
(en)
|
2010-08-02 |
2012-02-09 |
Population Diagnotics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
EP2616101B1
(de)
|
2010-09-14 |
2014-07-09 |
F.Hoffmann-La Roche Ag |
Verfahren zur reinigung von pegyliertem erythropoetin
|
US20120310140A1
(en)
|
2010-12-01 |
2012-12-06 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
EP2471543A1
(de)
|
2010-12-02 |
2012-07-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
ES2707579T3
(es)
|
2011-06-01 |
2019-04-04 |
Celularity Inc |
Tratamiento del dolor usando citoblastos placentarios
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
EP2739734A1
(de)
|
2011-08-03 |
2014-06-11 |
The Charlotte-Mecklenburg Hospital Authority d/b/a Carolina Healthcare System |
Behandlung von fibrose mit mikrorna-19b
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
WO2013067451A2
(en)
|
2011-11-04 |
2013-05-10 |
Population Diagnostics Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
EP2812452B1
(de)
|
2012-02-09 |
2020-05-27 |
Population Bio, Inc. |
Verfahren und zusammensetzungen zum screening und zur behandlung von entwicklungsstörungen
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
PT2814844T
(pt)
|
2012-02-15 |
2017-09-18 |
Novo Nordisk As |
Anticorpos que se ligam e bloqueiam recetor de acionamento expresso em células mieloides-1 (trem-1)
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US9494597B2
(en)
|
2012-04-02 |
2016-11-15 |
Ab Biosciences, Inc. |
Human control antibodies and uses therefor
|
DK2839013T3
(da)
*
|
2012-04-18 |
2020-09-14 |
Univ Leland Stanford Junior |
Ikke-disruptiv-gen-targetering
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US9976180B2
(en)
|
2012-09-14 |
2018-05-22 |
Population Bio, Inc. |
Methods for detecting a genetic variation in subjects with parkinsonism
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
CN103864913A
(zh)
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
JP2016519651A
(ja)
|
2013-03-15 |
2016-07-07 |
アンジェリカ セラピューティックス,インク. |
改質された毒素
|
EP2970420A4
(de)
|
2013-03-15 |
2016-08-17 |
Apotex Inc |
Erhöhte flüssigkeitsformulationsstabilität von erythropoietin-alpha durch aufreinigungsverarbeitung
|
EP3074037B1
(de)
|
2013-11-27 |
2020-10-07 |
Inis Biotech LLC |
Verfahren zur modulierung der angiogenese von auf eine anti-vegf behandlung refraktären karzinomen
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
KR102417915B1
(ko)
|
2014-03-21 |
2022-07-07 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
뉴클레아제 없는 게놈 편집
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
US10724096B2
(en)
|
2014-09-05 |
2020-07-28 |
Population Bio, Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
KR102617137B1
(ko)
|
2014-09-15 |
2023-12-27 |
칠드런'즈 메디컬 센터 코포레이션 |
히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
|
EP3015475A1
(de)
|
2014-10-31 |
2016-05-04 |
Novartis AG |
Säugetierzellen zur Expression von Cytomegalovirus-Antigenen
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
EP3031822A1
(de)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus-Antigene
|
US10632151B2
(en)
|
2015-01-22 |
2020-04-28 |
University Of Massachusetts |
Cancer immunotherapy
|
EP3048114A1
(de)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus-Antigene und Verwendungen davon
|
EP3047856A1
(de)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv-antigene und ihre verwendungen
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
JP7157981B2
(ja)
|
2016-03-07 |
2022-10-21 |
チャールストンファーマ, エルエルシー |
抗ヌクレオリン抗体
|
RU2021111187A
(ru)
|
2016-04-15 |
2021-04-29 |
Янссен Фармасьютикалз, Инк. |
Антитела против человеческого vista и их применение
|
CN109415427A
(zh)
|
2016-07-15 |
2019-03-01 |
豪夫迈·罗氏有限公司 |
用于纯化聚乙二醇化的促红细胞生成素的方法
|
WO2018144807A2
(en)
*
|
2017-02-02 |
2018-08-09 |
Massachusetts Institute Of Technology |
Engineered yeast as a method for bioremediation
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
WO2019129877A1
(en)
|
2017-12-29 |
2019-07-04 |
F. Hoffmann-La Roche Ag |
Process for providing pegylated protein composition
|
KR102497097B1
(ko)
|
2017-12-29 |
2023-02-06 |
에프. 호프만-라 로슈 아게 |
페길화 단백질 조성물의 제공 방법
|
JP7137625B2
(ja)
|
2017-12-29 |
2022-09-14 |
エフ.ホフマン-ラ ロシュ アーゲー |
Peg化タンパク質組成物を提供するための方法
|
EP4177356A1
(de)
|
2018-08-08 |
2023-05-10 |
PML Screening, LLC |
Verfahren zur beurteilung des risikos der entwicklung einer viruserkrankung unter verwendung eines genetischen tests
|
EP4004018A1
(de)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modifizierte humane cytomegalovirus-proteine
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|